Detalhe da pesquisa
1.
PD-L1 is required for estrogen-induced protection against severe EAE in IL-10 deficient mice1.
Metab Brain Dis
; 38(2): 589-599, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454506
2.
"Near Cure" treatment of severe acute EAE in MIF-1-deficient female and male mice with a bifunctional MHCII-derived molecular construct.
Cell Immunol
; 378: 104561, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35738135
3.
Brief report: Enhanced DRα1-mMOG-35-55 treatment of severe EAE in MIF-1-deficient male mice.
Cell Immunol
; 370: 104439, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607646
4.
Sex differences in EAE reveal common and distinct cellular and molecular components.
Cell Immunol
; 359: 104242, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190849
5.
MIF and D-DT are potential disease severity modifiers in male MS subjects.
Proc Natl Acad Sci U S A
; 114(40): E8421-E8429, 2017 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28923927
6.
A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury.
J Neuroinflammation
; 16(1): 14, 2019 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30683115
7.
Increased CD74 binding and EAE treatment efficacy of a modified DRα1 molecular construct.
Metab Brain Dis
; 34(1): 153-164, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30353480
8.
Sex-dependent treatment of chronic EAE with partial MHC class II constructs.
J Neuroinflammation
; 14(1): 100, 2017 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28477623
9.
DRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury.
Metab Brain Dis
; 32(5): 1395-1402, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28303450
10.
Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.
Cytokine
; 88: 62-70, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27573366
11.
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.
J Immunol
; 192(9): 4164-73, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24683185
12.
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Metab Brain Dis
; 31(2): 249-55, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26851955
13.
HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection.
J Neuroinflammation
; 12: 123, 2015 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26104759
14.
Surviving the storm: Dealing with COVID-19.
Cell Immunol
; 354: 104153, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32563849
15.
The use of flow cytometry to assess a novel drug efficacy in multiple sclerosis.
Metab Brain Dis
; 30(4): 877-84, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25502010
16.
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
Eur J Immunol
; 43(5): 1309-21, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23576302
17.
CD4 aptamer-RORγt shRNA chimera inhibits IL-17 synthesis by human CD4(+) T cells.
Biochem Biophys Res Commun
; 452(4): 1040-5, 2014 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25241192
18.
A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke.
Metab Brain Dis
; 29(1): 37-45, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24122483
19.
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance.
J Autoimmun
; 40: 96-110, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23026773
20.
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes.
Eur J Immunol
; 41(5): 1465-79, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21469129